Invention Grant
- Patent Title: Crystalline forms of potassium channel modulators
-
Application No.: US17287907Application Date: 2019-10-21
-
Publication No.: US11993586B2Publication Date: 2024-05-28
- Inventor: Gregg F. Keaney , Jun Xu , Wenfeng Xue
- Applicant: Novartis AG
- Applicant Address: CH Basel
- Assignee: Novartis AG
- Current Assignee: Novartis AG
- Current Assignee Address: CH Basel
- Agency: McCarter & English, LLP
- International Application: PCT/US2019/057203 2019.10.21
- International Announcement: WO2020/086456A 2020.04.30
- Date entered country: 2021-04-22
- Main IPC: C07D403/04
- IPC: C07D403/04
Abstract:
Provided herein are crystalline and amorphous forms of a compound having structural formula (1). Also provided are pharmaceutical compositions comprising the crystalline and amorphous forms, methods for their manufacture, and uses thereof for treating a variety of diseases, disorders or conditions, associated with potassium channels.
Public/Granted literature
- US20210395229A1 CRYSTALLINE FORMS OF POTASSIUM CHANNEL MODULATORS Public/Granted day:2021-12-23
Information query
